Literature DB >> 32240087

Primary Renal Carcinoid Tumor: Report of Two Cases.

Ramzi Jabaji1, Tyler Kern1, Dejun Shen2, William Chu3, Madhur Merchant4.   

Abstract

INTRODUCTION: Primary renal carcinoid tumors are a rare subset of neuroendocrine tumors arising in the kidneys. Although carcinoid syndrome has occasionally been described, most patients are asymptomatic at presentation. CASE PRESENTATIONS: We present 2 cases of primary renal carcinoid tumor and describe the workup, immunohistochemical analysis, treatment, and surveillance of each female patient. The first patient was found to have a renal mass on imaging during a workup of chronic abdominal pain and subsequently underwent a robotic radical nephrectomy. The second patient was found to have an incidental renal mass on imaging and subsequently underwent renal biopsy, followed by robot-assisted laparoscopic partial nephrectomy. In both cases, a gallium dotatate Ga 68-enhanced positron emission tomography/computed tomography scan was used to further assess disease burden. DISCUSSION: This report describes 2 cases of primary renal carcinoid tumor with unique presentations and management in our regional health care system. Because primary renal carcinoid tumors are quite uncommon, there are no clear established guidelines on preoperative imaging or posttreatment surveillance in patients with these tumors. There remains a large amount of variability in the diagnosis, workup, immunohistochemical analysis, treatment, and surveillance of patients with primary renal carcinoid tumors. As we learn more about this disease, we hope to optimize patient outcomes and standardize pretreatment workup and posttreatment surveillance.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32240087      PMCID: PMC7089591          DOI: 10.7812/TPP/19.147

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  8 in total

1.  Primary renal well-differentiated neuroendocrine tumour (carcinoid): next-generation sequencing study of 11 cases.

Authors:  Kristyna Pivovarcikova; Abbas Agaimy; Petr Martinek; Reza Alaghehbandan; Delia Perez-Montiel; Isabel Alvarado-Cabrero; Joanna Rogala; Naoto Kuroda; Boris Rychly; Slavko Gasparov; Kvetoslava Michalova; Michal Michal; Milan Hora; Tomas Pitra; Inna Tuckova; Simon Laciok; Jana Mareckova; Ondrej Hes
Journal:  Histopathology       Date:  2019-07       Impact factor: 5.087

2.  Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review.

Authors:  Edward M Wolin; Al Bowen Benson Iii
Journal:  Oncology       Date:  2019-04-24       Impact factor: 2.935

Review 3.  Primary carcinoid tumors of the kidney.

Authors:  Frederico R Romero; Soroush Rais-Bahrami; Sompol Permpongkosol; Samson W Fine; Sahar Kohanim; Thomas W Jarrett
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

4.  Five New Cases of Primary Renal Carcinoid Tumor: Case Reports and Literature Review.

Authors:  Joel E Rosenberg; Jacob A Albersheim; Niranjan J Sathianathen; Paari Murugan; Christopher J Weight
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

Review 5.  The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors.

Authors:  Amit Tirosh; Electron Kebebew
Journal:  Future Oncol       Date:  2017-10-26       Impact factor: 3.404

6.  A 5-decade analysis of 13,715 carcinoid tumors.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

7.  Updated population-based review of carcinoid tumors.

Authors:  Melinda A Maggard; Jessica B O'Connell; Clifford Y Ko
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

8.  Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis.

Authors:  Bohyun Kim; Han-Seong Kim; Kyung Chul Moon
Journal:  Diagn Pathol       Date:  2019-02-07       Impact factor: 2.644

  8 in total
  1 in total

1.  Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor.

Authors:  Hua Jiang; He Zhang
Journal:  Onco Targets Ther       Date:  2022-05-27       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.